Humacyte, Inc.
HUMA
$1.47
-$0.03-2.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.54% | 222.71% | 16.59% | -50.81% | -149.55% |
| Total Depreciation and Amortization | 4.55% | 2.29% | -1.36% | -0.98% | -10.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.49% | -908.95% | -554.41% | 169.52% | 1,936.90% |
| Change in Net Operating Assets | -134.45% | -105.24% | -179.88% | -51.58% | 217.56% |
| Cash from Operations | -24.06% | -4.59% | -39.48% | -76.11% | 5.80% |
| Capital Expenditure | -208.70% | 41.69% | 58.00% | -89.45% | 62.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -208.70% | 41.69% | 58.00% | -89.45% | -111.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.89% | -13.93% | -14.46% | -14.21% | 98.01% |
| Issuance of Common Stock | 310.80% | 9.28% | 19,726.88% | 400.00% | 728.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.26% | -- | -- | 454.20% | -101.59% |
| Cash from Financing | 563.81% | -25.57% | 15,325.67% | 211.13% | -107.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.09% | -48.91% | 224.70% | -61.19% | -46.61% |